Listen to The Lancet Oncology

Emma Grainger discusses articles on myelodysplastic syndromes, circulating tumour cells and prostate cancer, and palliative stents for oesophageal cancer.

Rob Brierley discusses two research articles investigating genetic subtypes of childhood acute lymphoblastic leukaemia.

Emma Grainger discusses liver transplantation criteria, sorafenib for liver cancer in the Asia-Pacific, and NICE guidance on erlotinib for non-small-cell lung cancer.

David Collingridge discusses a research article comparing microsurgery with total excision for basal-cell carcinoma of the face, and other content highlights.

Rob Brierley introduces the latest issue, including research articles about prostate cancer and a review highlighting the importance of appropriate palliative care.

John Sellors and Guglielmo Ronco discuss HPV screening for precursors of cervical cancer.

Sally van der Meer discusses highlights from the September journal in this issue's podcast, including a new treatment option for preventing bone mineral loss among pre-menopausal women receiving hormone therapy for early breast cancer.

The Lancet Oncology podcast - a global health theme for the August issue. Editor David Collingridge discusses the highlights, including cancer survival from five continents, and a review of cancer issues in Africa.

TLO Editor David Collingridge discusses some highlights from the July issue: radiofrequency ablation showing promise for the treatment of lung cancer; how a rare form of obesity could negatively affect treatment outcomes; and a discussion of a recent meeting at IARC in Lyon, France, concerning the latest evidence on smoke-free policies and the effects on public health.

Emma Cannell and Sally van der Meer discuss highlights from the June issue: a prospective pilot study assessing the role of stellate-ganglion block to treat hot flushes in survivors of breast cancer; also discussed is a Personal View about cancer of unknown primary (CUP), and the Leading Edge on public confidence in Merck's HPV vaccine.

Editor David Collingridge discusses highlights from the May issue: the natural history of cervical intraepithelial neoplasia; the effect of screening on prostate-cancer mortality in the USA and UK; and the launch of a series of reviews about cancer in indigenous populations, starting this month with cancer among indigenous Polynesians.

Editor David Collingridge discusses highlights from the April issue including: encouraging results from the START trials suggest fewer fractions of radiotherapy could revolutionise treatment of early stage breast cancer; how a phase II study investigating yttrium-90 labelled ibritumomab could have an important future role in the treatment of follicular non-Hodgkin lymphoma, and finally the pressin...

Dr David Collingridge, Editor of the Lancet Oncology, discusses highlights of the March issue in the first Lancet Oncology podcast. Two main topics are discussed: a research article highlighting how individuals in the United States who are under-insured or who have no medical insurance are at an increased risk of presenting with late-stage cancers; non-whites are at a similarly increased cancer ri...

Harriet Rumgay (International Agency for Research on Cancer, France) discusses the recent global burden of cancer in 2020 attributable to alcohol consumption study

Xuesong Han (American Cancer Society, Atlanta, GA, USA) discusses her study on changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA.

Dr. Wanda Cui (Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia) discusses her Review on measuring ovarian toxicity in clinical trials.

Doctor Philipp Karschnia (Ludwig-Maximilians-University of Munich, Munich, Germany) discusses the Response Assessment in Neuro Oncology consortium’s recommendations on standardised tissue sampling and processing during resection of diffuse intracranial glioma.

Professor Mike Sathekge (Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa) discusses his Article entitled, ‘Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre retrospective study.’

Dr Hisham Mehanna (University of Birmingham, Birmingham, UK) and Dr Sue Yom (University of California, San Francisco, San Francisco, CA, USA) discuss their four-paper Series on Head and Neck Cancer Consensus Recommendations in diagnosis and clinical trial endpoints.

Professor M Saiful Huq (Department of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, USA) and Dr Mostafa Aziz Sumon (Radiation Oncology, Kurmitola General Hospital, Dhaka, Bangladesh) discuss their Series on Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries.

Professor Ian Tannock (Princess Margaret Cancer Centre and the University of Toronto, Toronto, Canada) discusses his Policy Review on Common Sense Oncology principles for the design, analysis and reporting of phase 3 randomised clinical trials.

Jamie Prowse, Senior Editor at The Lancet Oncology, is joined by Professor Abdalla Awidi (Founder and Director of Stem Cell Therapy Center, University of Jordan, Amman, Jordan) to discuss The Lancet Oncology's Cancer control in the Middle East Series. The Series comprises five papers from regional experts who discuss the current outlook for cancer in the Middle East and future developmen...